Alkem features amongst the top 10 companies in the Neuro/CNS Therapy Area (TA). We offer therapy for Alzheimer’s, Dementia, Stroke, Migraine, Epilepsy, Depression and Neuropathic Pain Management. Over the last four years, we have significantly outperformed competitors, which has helped us get phenomenal growth. As per latest MAT (June 19), Alkem’s CNS TA is ranked 5th (AIOCD data) and we are continuously surging ahead.
Our CNS portfolio has the following key brands: